The BCL-2 family of apoptotic proteins encompasses key regulators proximal to irreversible cell damage. The BH3-only members of this family act as sentinels, interconnecting specific death signals to the core apoptotic pathway. Our previous data demonstrated a role for BH3-only BID in maintaining myeloid homeostasis and suppressing leukemogenesis. In the absence of Bid, mice accumulate chromosomal aberrations and develop a fatal myeloproliferative disorder resembling chronic myelomonocytic leukemia. Here, we describe a role for BID in preserving genomic integrity that places BID at an early point in the path to determine the fate of a cell. We show that BID plays an unexpected role in the intra-S phase checkpoint downstream of DNA damage distinct from its proapoptotic function. We further demonstrate that this role is mediated through BID phosphorylation by the DNA-damage kinase ATM. These results establish a link between proapoptotic Bid and the DNA-damage response.
Introduction
The BCL-2 family of proteins is predominantly situated upstream of irreversible cellular damage in the intrinsic apoptotic pathway (reviewed in Danial and Korsmeyer [2004] ). Pro-as well as antiapoptotic members contribute to apoptotic susceptibility and the predisposition to cancer. The BH3-only proapoptotic members connect specific proximal death signals with the multidomain proapoptotic molecules BAX and BAK that serve as an obligate gateway to apoptotic death. The multidomain antiapoptotic members bind and sequester BH3-only molecules to protect from activation of BAX, BAK as one mechanism of preventing death.
The BH3-only member BID serves the unique function of interconnecting the extrinsic death receptors for *Correspondence: sandra.zinkel@vanderbilt.edu 3 These authors contributed equally to this work. 4 The role of BID in normal development and cellular homeostasis has been characterized using mice in which Bid has been disrupted. When challenged with lethal doses of agonistic anti-Fas antibody, mice without BID are resistant to the ensuing Fas-induced hepatocellular apoptosis, indicating a critical role for a BIDdependent mitochondrial amplification loop in this liver cell death (Yin et al., 1999) . Despite this dramatic phenotype, Bid −/− mice successfully complete embryonic development and their livers appear grossly normal. However, as they age, Bid −/− mice spontaneously develop a myeloproliferative disorder that progresses to a fatal disease resembling chronic myelomonocytic leukemia (CMML). This indicates an essential role for BID in maintaining myeloid homeostasis and suppressing leukemogenesis (Zinkel et al., 2003) .
A critical question is how BID is involved in suppressing oncogenesis. While the loss of BID could theoretically reset death susceptibility in both intrinsic and extrinsic pathways, it is less obvious why the absence of BID should prove so oncogenic. A striking feature of the BID-deficient CMML is the frequent presence of genomic instability as evidenced by chromosomal translocation (Zinkel et al., 2003) . This suggests that BID might also serve a role in preserving genomic integrity.
Progression to malignancy is a multistep process in which a succession of genetic changes culminates in phenotypic changes (Jacks and Weinberg, 2002) . Maintenance of genomic integrity is of fundamental importance to the survival and health of an organism. DNA is highly reactive and subject to damage by multiple reagents including reactive oxygen species, methylating agents, both UV and IR as well as stochastic errors that can arise during DNA replication and recombina-tion. Cells respond to the presence of DNA damage by activating cell cycle checkpoints and repair mechanisms, and ultimately the damaged cell is eliminated through apoptosis.
The cellular response to DNA damage varies by cell type. For example, fibroblasts are relatively resistant to DNA damage-induced apoptosis; they prevent proliferation of mutations by entering into long-term G1 or G2 arrest (Baus et −/− mice progress to a high incidence of myeloid malignancy with considerable genomic instability in that cell type. Wild-type hematopoietic cells have a marked propensity for apoptosis in response to DNA damage; yet in the absence of BID, myeloid cells accumulate mutations, resist apoptosis, and display aspects of unchecked proliferation. This suggests that BID may itself play a role in DNA repair, in cell cycle checkpoint response, or in integrating apoptosis and the DNA repair response. In this study, we describe a novel role for BID in preserving genomic integrity that places BID at an early point in the path to determine the fate of a cell. We show that BID plays an unexpected role in the intra-S phase checkpoint downstream of DNA damage. We further demonstrate that this role is mediated through BID phosphorylation by the DNA-damage kinase ATM. Since the casein kinase family has been reported to phosphorylate BID, (Desagher et al., 1999) , we also tested specific inhibitors of these kinases. Inhibitors of either casein kinase 1 (CKI-7) or casein kinase 2 (TBB) do not abolish hydroxyurea-induced phosphorylation of BID at serine 61 or 78 ( Figure S7A, lanes 4 and 3, respectively, versus lane 2) , suggesting that DNA dam- age-induced BID phosphorylation may be mediated by a kinase distinct from the casein kinases.
Results

Bid
BID Is a Substrate of ATM/ATR
To further elucidate the kinase responsible for regulation of BID phosphorylation, we evaluated a series of MEFs deficient for the DNA repair kinases ATM, ATR, and DNA-PKcs. In the absence of ATM, phosphorylation of BID at serines 61/64 and 78 in response to hydroxyurea, UV light, and ionizing radiation is nearly completely abrogated ( Figure 6E, lanes 6, 7, and 8 To determine if ATM and/or ATR could directly phosphorylate BID, we performed in vitro kinase assays using FLAG-tagged ATM and ATR and recombinant mouse BID. Wild-type but not kinase-inactive human ATM and ATR phosphorylate BID in vitro ( Figure 6I,  lanes 2 and 4 versus lanes 3 and 5) , suggesting that BID can serve as a substrate of both ATM and ATR. Taken together with the above genetic studies, ATM or a kinase downstream of ATM is strongly implicated as the major kinase-mediating BID phosphorylation following DNA damage.
Bid
−/− MPCs Have an Intra-S Phase Checkpoint Defect
To further dissect the cell cycle S phase aberration in Bid −/− MPCs, we tested the ability of these MPCs to (Figures 7A and 7C, respectively) . Bid −/− -activated T cells ( Figure 7D ) display a similar abrogation of the IR-induced replication arrest, confirming that this intra-S phase checkpoint defect is a general feature of BID deficiency. Wild-type BID as well as BH3 mutant BID transduced into Bid −/− MPCs restored replication arrest following IR ( Figure 7C, green and yellow bars, respectively) , providing further evidence that the checkpoint defect is mediated by BID. Taken together, the above data provide strong evidence that BID plays a role in the intra-S phase checkpoint and that this role is mediated by a region of BID distinct from its prodeath domain. serving genomic integrity that places BID at an early point in the path to determine the fate of a cell. Here, we show that BID plays an unexpected role in the intra-S phase checkpoint downstream of DNA damage that is distinct from its proapoptotic role. ATM/ATR-mediated BID phosphorylation at serine 78 is required for the IR-mediated intra-S phase checkpoint. An intact BH3 domain, which is required for apoptosis, is not required for the BID-mediated S phase effects or the increased sensitivity to replicative stress, suggesting that the role of BID in the DNA-damage response is distinct from its proapoptotic function. Furthermore, like ATM and ATR (Dart et al., 2004; Gately et al., 1998) , BID localizes to the chromatin fraction of the nucleus following treatment with DNA-damaging agents.
The S Phase Role of BID Is Mediated by Phosphorylation at Position 78
One interesting feature of Bid −/− myeloid cells is their apparent lack of sensitivity to IR or UV irradiation. Our data strongly suggest that ATM is a major upstream kinase of BID following DNA damage, indicating that this is an important signaling pathway. Bid-deficient hematopoietic cells display a profound defect in the intra-S phase checkpoint in response to IR, demonstrating a biological role for BID downstream of ATM signaling. Of note, there is precedence for important signaling pathways that do not result in a phenotype with respect to viability. MPCs were isolated by lineage depletion followed by positive selection of Sca-1 + cells by magnetic beads (Miltenyi). Cells were cultured in IMDM, 20% fetal calf serum (FCS), 100 U/ml penicillinstreptomycin, 2 mM glutamine, 10 ng/ml IL-3, 20 ng/ml stem cell factor (SCF), 10 ng/ml GM-CSF, and 2 ng/ml G-CSF for 3 days at 37°C in 5% CO 2 and then treated with DNA-damaging agents as above.
Populations enriched in primary peripheral CD8 + T cells were obtained from Bid −/− mice, which have been bred into an H-Y T cell receptor transgenic mouse model (Kisielow et al., 1988) . After sacrifice by CO 2 asphyxiation, spleens were harvested from Bid −/− as well as Bid +/+ mice; splenocytes were isolated and incubated in RPMI + IL-2 + 0.1 M antigenic peptide (HY) for 3 days and treated with mitomycin c and hydroxyurea, and cell viability was measured after 24 hr as above. S61A BID and S78A BID were obtained using the Quickchange XL site-directed mutagenesis kit (Stratagene) and cloned into the BamHI and EcoRI sites of the pBABE retroviral expression vector, and the NotI/XhoI sites of pOZ-FH-N vector. BIDmIII.2, BIDmIII.3, and BIDmIII.4 were amplified by PCR from pCDNA3 harboring these constructs (Wang et al., 1996) and cloned into the BamHI/ EcoRI sites of pBABE puro.
Metaphase Spreads
Epitope-tagged BID was generated by cloning the cDNA for BID into pOZ-FH-C (Nakatani and Ogryzko, 2003) to generate BID that is tagged at the C terminus with FLAG and HA. In Vitro Kinase Assays 293T cells were transiently transfected with pCDNA3-FLAG ATR WT or kinase inactive (KI) (K2327R) (Tibbetts et al., 1999) or pCDNA3-FLAG-ATM WT or KI (Canman et al., 1998) or pCDNA3 vector alone using Fugene 6 reagent. In vitro kinase assays were performed using standard methods (details in the Supplemental Experimental Procedures).
Bid Immunoprecipitations
MPCs or MEFs were lysed in TNE buffer, and endogenous mouse Bid was immunoprecipitated with biotinylated anti-Bid antibody. Immunoprecipitates were separated on 12% SDS-PAGE and the phosphorylation status of Bid was monitored using phosphospecific antisera recognizing S61/64, S61, or S78. Total Bid levels were monitored using an Anti-Bid antibody . 
Kinase Inhibitor Treatments
